Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Pathogens (Basel, Switzerland)|January 21, 2023
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine DevelopmentChristin Schmidt, Barbara S SchnierleDrug Design, Development and Therapy|October 24, 2022
Chikungunya Vaccine Candidates: Current Landscape and Future ProspectsChristin Schmidt, Barbara S SchnierleViruses|July 2, 2021
Development of a Sensitive Detection Method for Alphaviruses and Its Use as a Virus Neutralization AssayChristin Schmidt, Mario Perkovic, Barbara S SchnierleViruses|July 27, 2024
The Stop Codon after the nsp3 Gene of Ross River Virus (RRV) Is Not Essential for Virus Replication in Three Cell Lines Tested, but RRV Replication Is Attenuated in HEK 293T CellsChristin Schmidt, Julia Gerbeth, Christine von Rhein, et al.Molecular Therapy. Nucleic Acids|June 6, 2022
A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infectionsChristin Schmidt, Erik Haefner, Julia Gerbeth, et al.Vaccines|September 23, 2022
A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune ResponsesChristin Schmidt, Florian D Hastert, Julia Gerbeth, et al.The Journal of General Virology|April 8, 2021
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infectionLisa Henss, Arne Auste, Christoph Schürmann, et al.Trends in Microbiology|November 30, 2019
A New Host Factor Essential for Chikungunya VirusBarbara S SchnierleViruses|September 23, 2022
Monkeypox Goes North: Ongoing Worldwide Monkeypox Infections in HumansBarbara S SchnierleViruses|November 23, 2019
Cellular Attachment and Entry Factors for Chikungunya VirusBarbara S SchnierlePageof 8